Search | IOVS | ARVO Journals

Showing 1 – 20 of 26

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Involvement of epidermal growth factor receptor pathway in experimental autoimmune uveoretinitis

Koichi Yokoi; Kenichi Namba; Miyuki Murata; Kayo Suzuki; Keitaro Hase; Daiju Iwata; Nobuyoshi Kitaichi; Miki Hiraoka; Susumu Ishida

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2991.

Vision Sciences Society Annual Meeting Abstract September 2019

The effect of spatial properties on trypophobia

Kanichi Fukumoto; Mototsugu Hayashi; Kenji Yokoi

Journal of Vision. 2019; 19(10):32a. https://doi.org/10.1167/19.10.32a

Vision Sciences Society Annual Meeting Abstract September 2019

The effect of eye movements in preferential decision

Dan Uemura; Shouta Katayama; Kenji Yokoi

Journal of Vision. 2019; 19(10):126. https://doi.org/10.1167/19.10.126

ARVO Annual Meeting Abstract July 2019

The Treatment Effect of 0.1% Tacrolimus Eye Drops in Young and Elder Vernal Keratoconjunctivitis Patients

Keiko Yokoi; Norihiko Yokoi; Mayumi Ueta; Chie Sotozono

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6713.

ARVO Annual Meeting Abstract April 2010

The Role of Cd40/cd40l Costimulatory Pathway in Experimental Induced Choroidal Neovascularization (cnv)

K. Umazume; T. Hattori; Y. Okunuki; Y. Usui; K. Yokoi; H. Akiba; M. Takeuchi; H. Goto

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):403.

ARVO Annual Meeting Abstract April 2009

Comparison of Ranibizumab and Bevacizumab in Animal Models of Subretinal Neovascularization (NV)

K. Miki; M. Matsuoka; D. Muramatsu; A. Miki; K. Yokoi; C. Seidel; S. F. Hackett; P. A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):783.

ARVO Annual Meeting Abstract May 2008

Inducible Transgene Expression After Intraocular Injection of an Inducible Expression Cassette Packaged in Adeno-Associated Viral (AAV) Vector

K. Yokoi; S. Ueno; K. Miki; D. Muramatsu; P. A. Campochiaro; R. J. Samulski

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):878.

ARVO Annual Meeting Abstract May 2008

Antioxidants Reduce Retinal and Choroidal Neovascularization

A. Dong; B. Xie; K. Yokoi; S. F. Hackett; P. A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3445.

Retinal Cell Biology April 2008

Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization

PDF

Katsuji Kiuchi; Masato Matsuoka; Jenny C. Wu; Raquel Lima e Silva; Muralitharan Kengatharan; Mary Verghese; Shinji Ueno; Katsutoshi Yokoi; Naw Htee Khu; John P. Cooke; Peter A. Campochiaro
TAGS: choroidal neovascularization, mecamylamine, nicotine, endothelial cells
Invest. Ophthalmol. Vis. Sci.. 2008; 49(4):1705-1711. https://doi.org/10.1167/iovs.07-0089

Research Article March 2008

Dynamic distortion of visual position representation around moving objects

PDF

Katsumi Watanabe; Kenji Yokoi
TAGS: motion, perception, photopsia
Journal of Vision. 2008; 8(3):13. https://doi.org/10.1167/8.3.13

Retinal Cell Biology July 2007

Ocular Gene Transfer with Self-Complementary AAV Vectors

PDF

Katsutoshi Yokoi; Shu Kachi; H. Steve Zhang; Philip D. Gregory; S. Kaye Spratt; R. Jude Samulski; Peter A. Campochiaro
TAGS: gene transfer techniques, spatial vectors, injections
Invest. Ophthalmol. Vis. Sci.. 2007; 48(7):3324-3328. https://doi.org/10.1167/iovs.06-1306

Vision Sciences Society Annual Meeting Abstract June 2007

2 deg. narrowed field of view can explain the process speed of tactile search for change

Takako Yoshida; Kenji Yokoi; Yuki Miyazaki; Hiromi Wake; Tenji Wake

Journal of Vision. 2007; 7(9):689. https://doi.org/10.1167/7.9.689

ARVO Annual Meeting Abstract May 2007

Conditional Knockdown of VEGF Family Members in the Eye

S. Ueno; K. Yokoi; M. Matsuoka; E. Keshet; P. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1754.

ARVO Annual Meeting Abstract May 2007

Ocular Gene Transfer With Self Complementary AAV Vectors

S. Kachi; K. Yokoi; S. Zhang; P. Gregory; R. J. Samulski; P. A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4607.

ARVO Annual Meeting Abstract May 2007

An Engineered Zinc Finger Protein Transcription Factor Promoting Expression of Pigment Epithelium-Derived Factor Yields Long-Term Inhibition of Choroidal Neovascularization

K. Yokoi; H. S. Zhang; S. Ueno; N. H. Khu; R. Surosky; L. M. Africa; P. D. Gregory; P. A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4618.

ARVO Annual Meeting Abstract May 2006

Delivery of Angioinhibitory Genes Using the VMD2 Promoter in Lentiviral Vectors Results in Selective Expression in RPE and Inhibition of Choroidal Neovascularization

S. Kachi; K. Binley; N. Umeda; H. Akiyama; K. Yokoi; M. Kachi; W. Xiao; M. Espa; S. Naylor; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):906.

ARVO Annual Meeting Abstract May 2006

Development of an EIAV Lentiviral Based Gene Therapy, RetinoStat®, for the Treatment of CNV Age–Related Macular Degeneration

K.M. Binley; S. Kachi; N. Umeda; H. Akiyama; K. Yokoi; W. Xiao; M. Kachi; S. Iqball; S. Naylor; P. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):908.

ARVO Annual Meeting Abstract May 2006

Inhibition of Laser–Induced Choroidal Neovascularization in Mice Using Antisense Oligonucleotides Directed Against HIF–1 or HIF–1ß

T.W. Lauer; S.F. Hackett; R. Formica; K. Yokoi; N.H. Khu; S. Henry; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1428.

ARVO Annual Meeting Abstract May 2006

Engineered Zinc Finger Protein Transcription factors as a Potential Therapy for Ocular Neovascularization

H.S. Zhang; S. Kachi; M. Kachi; P.–Q. Liu; H. Akiyama; N. Umeda; K. Yokoi; S. Hackett; P.D. Gregory; P.A. Campochiaro

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1786.

Vision Sciences Society Annual Meeting Abstract September 2005

Distortion of positional representation of visual objects by motion signals

Kenji Yokoi; Katsumi Watanabe

Journal of Vision. 2005; 5(8):206. https://doi.org/10.1167/5.8.206

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Involvement of epidermal growth factor receptor pathway in experimental autoimmune uveoretinitis

The effect of spatial properties on trypophobia

The effect of eye movements in preferential decision

The Treatment Effect of 0.1% Tacrolimus Eye Drops in Young and Elder Vernal Keratoconjunctivitis Patients

The Role of Cd40/cd40l Costimulatory Pathway in Experimental Induced Choroidal Neovascularization (cnv)

Comparison of Ranibizumab and Bevacizumab in Animal Models of Subretinal Neovascularization (NV)

Inducible Transgene Expression After Intraocular Injection of an Inducible Expression Cassette Packaged in Adeno-Associated Viral (AAV) Vector

Antioxidants Reduce Retinal and Choroidal Neovascularization

Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization

Dynamic distortion of visual position representation around moving objects

Ocular Gene Transfer with Self-Complementary AAV Vectors

2 deg. narrowed field of view can explain the process speed of tactile search for change

Conditional Knockdown of VEGF Family Members in the Eye

Ocular Gene Transfer With Self Complementary AAV Vectors

An Engineered Zinc Finger Protein Transcription Factor Promoting Expression of Pigment Epithelium-Derived Factor Yields Long-Term Inhibition of Choroidal Neovascularization

Delivery of Angioinhibitory Genes Using the VMD2 Promoter in Lentiviral Vectors Results in Selective Expression in RPE and Inhibition of Choroidal Neovascularization

Development of an EIAV Lentiviral Based Gene Therapy, RetinoStat®, for the Treatment of CNV Age–Related Macular Degeneration

Inhibition of Laser–Induced Choroidal Neovascularization in Mice Using Antisense Oligonucleotides Directed Against HIF–1 or HIF–1ß

Engineered Zinc Finger Protein Transcription factors as a Potential Therapy for Ocular Neovascularization

Distortion of positional representation of visual objects by motion signals

To View More...

You must be signed into an individual account to use this feature.